- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in Moderna
US Not Liable In Moderna Covid-19 Vaccine Patent Case: Second Judge
A Moderna spokesperson said in a statement that the company "respectfully disagrees" with the decision and is confident that discovery will support its position. Representatives for Alnylam did not immediately respond to a request for comment.
Read MoreModerna/Merck Cancer Vaccine Plus Keytruda Delays Skin Cancer Return: Study
The findings suggest that adding a personalized cancer vaccine based on mRNA technology to Keytruda, which revs up the immune response, could prolong the time patients have without recurrence or death, said Dr Jeffrey Weber, NYU Langone Perlmutter Cancer Center, who presented the findings.
Read MorePfizer/Biontech, Moderna Prepare For London Trial 2024
Pfizer and BioNTech sued Moderna in London in September, seeking to revoke two of Moderna's patents in relation to its messenger RNA (mRNA) vaccines.
Read MoreModerna Declines China's Request To Disclose Vaccine Technology
The Cambridge, Massachusetts-based pharmaceutical company turned down China's request to hand over the recipe for its mRNA vaccine because of commercial and safety concerns
Read MoreU.S FDA Sets June Meeting For Moderna, Pfizer Small Children COVID-vaccines
The June 14 meeting will consider Moderna's emergency use authorization request for youth aged six to 17 years, the FDA said.White House COVID-19 response coordinator Dr. Ashish Jha said on Sunday he expects a U.S. Food and Drug Administration decision on authorizing Moderna's vaccine for children under age five within the next few weeks
Read MoreCOVID-19 Vaccine sales Push Moderna Q4 Profit To $12 Bn
Moderna's COVID-19 vaccine is the only product the drugmaker has on the market
Read MoreModerna COVID-19 Jabs Likely To Cause Heart Inflammation Than Pfizer's: Study
Earlier studies from Israel and the United States have indicated an increased risk of heart inflammation after inoculation with the mRNA-vaccines developed by Pfizer-BioNTech and Moderna.
Read MoreModerna Covid Vaccine Produces Lasting Immune Response, Study Finds
They found that the Moderna vaccine spurs an adaptive immune response to the SARS-CoV-2 spike protein nearly identical to the immune system's response to a natural infection.
Read MoreModerna, Japan Partner Recall 1.6 Million Doses
The companies on Aug. 26 announced suspension of 1.63 million doses produced at the line after reports of contamination.
Read MoreJapan Suspends 1.63M Doses Of Moderna Over Contamination
The health ministry said contamination was reported from multiple vaccination sites. Some doses might have been administered, but no adverse health effects have been reported so far
Read MoreNo Sign Of Pfizer, Moderna Covid Vaccines In Breast Milk: Study
The researchers at University of California, San Francisco (USCF) in the US analysed the breast milk of seven women after they received the Pfizer and Moderna mRNA vaccines, and found no trace of the preventives.
Read MoreIndia Offered 7.5 Mn Doses Of Moderna Vaccine; No Consensus On Indemnity Clause Yet: Sources
NITI Aayog member (Health) Dr V K Paul had recently said the government is working actively with Moderna to see how its vaccine can be imported and made available in the country.
Read MoreCases Of Lambda Covid-19 Variant Found In Canada
The Public Health Agency of Canada is monitoring Lambda to see how it spreads and how it responds to vaccines,
Read MorePfizer, Moderna Vaccines Cut Covid-19 Risk By 91%: Study
The mRNA vaccines by Pfizer and Moderna contain genetic instructions for our cells to make the spike protein of the SARS-CoV-2, which the virus uses to infect and enter the human cells.
Read MoreSerum Institute Asks Govt To Take Up Inclusion Of Covishield In Vaccination Passport With EU
The letter also mentions that AstraZeneca-SII Covishield has been manufactured under technology transfer from Oxford/AstraZeneca and that clinical trials of the vaccine have been conducted successfully abroad and has been approved by MHRA for emergency use approval.
Read More